If this file opens in Compatibility Mode using Microsoft Word, convert to the latest document format to avoid potential formatting issues.	

OP RSH GO42784 (NASBP B-61) GIREDESTRANT/JAIN ARM B	

Types:      Research Oncology Treatment
Synonyms:  LIDERA, GIREDESTRANT, GO42784, NASBP B-61, B-61, NASBP, ARM B

Cycle 1	Repeat 1 time	Cycle length: 28 days	Day 1	Perform every 1 day x1		Nursing Orders
  	ONC NURSING COMMUNICATION 22	Interval: --	Occurrences: --	Comments:	EORTC QLQ-C30, EQ-5D-5L, PRO-CTCAE, single-item GP5, EORTC QLQ-BR23
§  Administered before patient receives information on disease status
			Cardiology
  	ECG 12-LEAD	Interval: --	Occurrences: --	Comments:	Performed prior to other medical procedures scheduled at the same time (e.g. vitals and lab draws) 

Single ECG, but abnormalities to be confirmed with ECG in triplicate
			Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
			Nursing Orders
  	ONC NURSING COMMUNICATION 62	Interval: --	Occurrences: --	Comments:	Perform limited, symptom-directed exam at specified timepoints or as clinically indicated. During the visit, sites can conduct a general well-being and symptom-directed questionnaire

Assessment acceptable for Cycle1 Day 1 if done within prior 7 days
			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		☑	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		☑	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		☑	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
		☑	ZZURINALYSIS, MICRO UA SCREEN WITH MICROSCOPY	Interval: --	Occurrences: --	Comments:	Dipstick - pH, specific gravity, glucose, protein, ketones, and blood
Microscopic - sediment, RBC, WBC, casts, crystals, epithelial cells, and bacteria
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	Serum test to be done within 7 days of treatment start and urine test within 24 hours of treatment start for all women of childbearing potential. Positive urine test to be confirmed with serum test
		  	HCG QUALITATIVE, URINE SCREEN	Interval: --	Occurrences: --	Comments:	Serum test to be done within 7 days of treatment start and urine test within 24 hours of treatment start for all women of childbearing potential. Positive urine test to be confirmed with serum test
			Chemotherapy
  	tamoxifen (NOLVADEX) 20 MG chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	letrozole (FEMARA) 2.5 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	anastrozole (ARIMIDEX) 1 mg chemo tablet	Dose: 1 mg	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	exemestane (AROMASIN) 25 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review
					
Cycle 2	Repeat 1 time	Cycle length: 28 days	Day 1	Perform every 28 days x1		Nursing Orders
  	ONC NURSING COMMUNICATION 22	Interval: --	Occurrences: --	Comments:	PRO-CTCAE, single-item GP5, 

Administered before patient receives information on disease status
			Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
			Nursing Orders
  	ONC NURSING COMMUNICATION 62	Interval: --	Occurrences: --	Comments:	Perform limited, symptom-directed exam at specified timepoints or as clinically indicated. During the visit, sites can conduct a general well-being and symptom-directed questionnaire

Assessment acceptable for Cycle1 Day 1 if done within prior 7 days
			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		☑	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	All women of childbearing potential now done monthly.
			Chemotherapy
  	tamoxifen (NOLVADEX) 20 MG chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	letrozole (FEMARA) 2.5 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	anastrozole (ARIMIDEX) 1 mg chemo tablet	Dose: 1 mg	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	exemestane (AROMASIN) 25 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review
					
Cycle 3	Repeat 1 time	Cycle length: 28 days	Day 1	Perform every 1 day x1		Nursing Orders
  	ONC NURSING COMMUNICATION 22	Interval: --	Occurrences: --	Comments:	EORTC QLQ-C30, EQ-5D-5L, PRO-CTCAE, single-item GP5, 
§  Administered before patient receives information on disease status
			Cardiology
  	ECG 12-LEAD	Interval: --	Occurrences: --	Comments:	Performed prior to other medical procedures scheduled at the same time (e.g. vitals and lab draws) 

Single ECG, but abnormalities to be confirmed with ECG in triplicate
			Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
			Nursing Orders
  	ONC NURSING COMMUNICATION 62	Interval: --	Occurrences: --	Comments:	Perform limited, symptom-directed exam at specified timepoints or as clinically indicated. During the visit, sites can conduct a general well-being and symptom-directed questionnaire

And ECOG performance score
			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		☑	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
			Labs
☑	FOLLICLE STIMULATING HORMONE	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and men and women receiving an LHRH agonist
		☑	ESTRADIOL LEVEL	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and women receiving an LHRH agonist
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	All women of childbearing potential now done monthly.
			Chemotherapy
  	tamoxifen (NOLVADEX) 20 MG chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	letrozole (FEMARA) 2.5 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	anastrozole (ARIMIDEX) 1 mg chemo tablet	Dose: 1 mg	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	exemestane (AROMASIN) 25 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review
					
Cycle 6	Repeat 1 time	Cycle length: 84 days	Day 1	Perform every 1 day x1		Nursing Orders
  	ONC NURSING COMMUNICATION 22	Interval: --	Occurrences: --	Comments:	EORTC QLQ-C30, EQ-5D-5L, PRO-CTCAE, single-item GP5, PRO CTSQ

§  Administered before patient receives information on disease status
			Cardiology
  	ECG 12-LEAD	Interval: --	Occurrences: --	Comments:	Performed prior to other medical procedures scheduled at the same time (e.g. vitals and lab draws) 

Single ECG, but abnormalities to be confirmed with ECG in triplicate
			Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
			Nursing Orders
  	ONC NURSING COMMUNICATION 62	Interval: --	Occurrences: --	Comments:	Perform limited, symptom-directed exam at specified timepoints or as clinically indicated. During the visit, sites can conduct a general well-being and symptom-directed questionnaire

And ECOG performance score
			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		☑	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
			Labs
☑	FOLLICLE STIMULATING HORMONE	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and men and women receiving an LHRH agonist
		☑	ESTRADIOL LEVEL	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and women receiving an LHRH agonist
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	All women of childbearing potential now done monthly.
			Chemotherapy
  	tamoxifen (NOLVADEX) 20 MG chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	letrozole (FEMARA) 2.5 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	anastrozole (ARIMIDEX) 1 mg chemo tablet	Dose: 1 mg	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	exemestane (AROMASIN) 25 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review
					
Cycle 9	Repeat 1 time	Cycle length: 84 days	Day 1	Perform every 1 day x1		Nursing Orders
  	ONC NURSING COMMUNICATION 22	Interval: --	Occurrences: --	Comments:	EORTC QLQ-C30, EQ-5D-5L, PRO-CTCAE, single-item GP5, 
§  Administered before patient receives information on disease status
			Cardiology
  	ECG 12-LEAD	Interval: --	Occurrences: --	Comments:	Performed prior to other medical procedures scheduled at the same time (e.g. vitals and lab draws) 

Single ECG, but abnormalities to be confirmed with ECG in triplicate
			Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
			Nursing Orders
  	ONC NURSING COMMUNICATION 62	Interval: --	Occurrences: --	Comments:	Perform limited, symptom-directed exam at specified timepoints or as clinically indicated. During the visit, sites can conduct a general well-being and symptom-directed questionnaire

And ECOG performance score
			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
			Labs
☑	FOLLICLE STIMULATING HORMONE	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and men and women receiving an LHRH agonist
		☑	ESTRADIOL LEVEL	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and women receiving an LHRH agonist
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	All women of childbearing potential now done monthly.
			Chemotherapy
  	tamoxifen (NOLVADEX) 20 MG chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	letrozole (FEMARA) 2.5 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	anastrozole (ARIMIDEX) 1 mg chemo tablet	Dose: 1 mg	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	exemestane (AROMASIN) 25 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review
					
Cycle 12	Repeat 1 time	Cycle length: 84 days	Day 1	Perform every 1 day x1		Nursing Orders
  	ONC NURSING COMMUNICATION 22	Interval: --	Occurrences: --	Comments:	EORTC QLQ-C30, EQ-5D-5L, PRO-CTCAE, single-item GP5, PRO: CTSQ, EORTC QLQ-BR23
§  Administered before patient receives information on disease status
			Cardiology
  	ECG 12-LEAD	Interval: --	Occurrences: --	Comments:	Performed prior to other medical procedures scheduled at the same time (e.g. vitals and lab draws) 

Single ECG, but abnormalities to be confirmed with ECG in triplicate
			Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
		  	HEIGHT AND WEIGHT	Interval: --	Occurrences: --			Nursing Orders
  	ONC NURSING COMMUNICATION 62	Interval: --	Occurrences: --	Comments:	Perform limited, symptom-directed exam at specified timepoints or as clinically indicated. During the visit, sites can conduct a general well-being and symptom-directed questionnaire

And ECOG performance score
			Imaging
  	MRI BREAST W WO CONTRAST BILATERAL	Interval: --	Occurrences: --	Comments:	o   bilateral mammogram or breast MRI to be performed yearly from that performed at screening/surgery as per clinical practice and/or as clinically indicated based on findings from physical examination.
o   Breast imaging must be performed on both breasts, unless a mastectomy has been performed
		  	MAMMO DIGITAL DIAGNOSTIC BILATERAL	Interval: --	Occurrences: --	Comments:	o   bilateral mammogram or breast MRI to be performed yearly from that performed at screening/surgery as per clinical practice and/or as clinically indicated based on findings from physical examination.
o   Breast imaging must be performed on both breasts, unless a mastectomy has been performed
			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
			Labs
  	LIPID PANEL	Interval: --	Occurrences: --	Comments:	Cholesterol, HDL, LDL, triglycerides after at least 8 hours of fasting
			Labs
☑	FOLLICLE STIMULATING HORMONE	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and men and women receiving an LHRH agonist
		☑	ESTRADIOL LEVEL	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and women receiving an LHRH agonist
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	All women of childbearing potential now done monthly.
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review
					
Cycle 15 	Repeat 1 time	Cycle length: 84 days	Day 1	Perform every 1 day x1		Nursing Orders
  	ONC NURSING COMMUNICATION 22	Interval: --	Occurrences: --	Comments:	EORTC QLQ-C30, EQ-5D-5L, PRO-CTCAE, single-item GP5, 
§  Administered before patient receives information on disease status
			Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
			Nursing Orders
  	ONC NURSING COMMUNICATION 62	Interval: --	Occurrences: --	Comments:	Perform limited, symptom-directed exam at specified timepoints or as clinically indicated. During the visit, sites can conduct a general well-being and symptom-directed questionnaire

And ECOG performance score
			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
			Labs
☑	FOLLICLE STIMULATING HORMONE	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and men and women receiving an LHRH agonist
		☑	ESTRADIOL LEVEL	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and women receiving an LHRH agonist
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	All women of childbearing potential now done monthly.
			Chemotherapy
  	tamoxifen (NOLVADEX) 20 MG chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	letrozole (FEMARA) 2.5 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	anastrozole (ARIMIDEX) 1 mg chemo tablet	Dose: 1 mg	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	exemestane (AROMASIN) 25 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review
					
Cycle 18	Repeat 1 time	Cycle length: 84 days	Day 1	Perform every 1 day x1		Nursing Orders
  	ONC NURSING COMMUNICATION 22	Interval: --	Occurrences: --	Comments:	EORTC QLQ-C30, EQ-5D-5L, PRO-CTCAE, single-item GP5, PRO CTSQ

§  Administered before patient receives information on disease status
			Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
			Nursing Orders
  	ONC NURSING COMMUNICATION 62	Interval: --	Occurrences: --	Comments:	Perform limited, symptom-directed exam at specified timepoints or as clinically indicated. During the visit, sites can conduct a general well-being and symptom-directed questionnaire

And ECOG performance score
			Cardiology
  	ECG 12-LEAD	Interval: --	Occurrences: --	Comments:	Performed prior to other medical procedures scheduled at the same time (e.g. vitals and lab draws) 

Single ECG, but abnormalities to be confirmed with ECG in triplicate
			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
			Labs
☑	FOLLICLE STIMULATING HORMONE	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and men and women receiving an LHRH agonist
		☑	ESTRADIOL LEVEL	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and women receiving an LHRH agonist
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	All women of childbearing potential now done monthly.
			Chemotherapy
  	tamoxifen (NOLVADEX) 20 MG chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	letrozole (FEMARA) 2.5 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	anastrozole (ARIMIDEX) 1 mg chemo tablet	Dose: 1 mg	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	exemestane (AROMASIN) 25 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review
					
Cycle 21	Repeat 1 time	Cycle length: 84 days	Day 1	Perform every 1 day x1		Nursing Orders
  	ONC NURSING COMMUNICATION 22	Interval: --	Occurrences: --	Comments:	EORTC QLQ-C30, EQ-5D-5L, PRO-CTCAE, single-item GP5, 
§  Administered before patient receives information on disease status
			Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
			Nursing Orders
  	ONC NURSING COMMUNICATION 62	Interval: --	Occurrences: --	Comments:	Perform limited, symptom-directed exam at specified timepoints or as clinically indicated. During the visit, sites can conduct a general well-being and symptom-directed questionnaire

And ECOG performance score
			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
			Labs
☑	FOLLICLE STIMULATING HORMONE	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and men and women receiving an LHRH agonist
		☑	ESTRADIOL LEVEL	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and women receiving an LHRH agonist
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	All women of childbearing potential now done monthly.
			Chemotherapy
  	tamoxifen (NOLVADEX) 20 MG chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	letrozole (FEMARA) 2.5 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	anastrozole (ARIMIDEX) 1 mg chemo tablet	Dose: 1 mg	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	exemestane (AROMASIN) 25 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review
					
Cycle 24	Repeat 1 time	Cycle length: 84 days	Day 1	Perform every 1 day x1		Nursing Orders
  	ONC NURSING COMMUNICATION 22	Interval: --	Occurrences: --	Comments:	EORTC QLQ-C30, EQ-5D-5L, PRO-CTCAE, single-item GP5, PRO: CTSQ, EORTC QLQ-BR23
§  Administered before patient receives information on disease status
			Cardiology
  	ECG 12-LEAD	Interval: --	Occurrences: --	Comments:	Performed prior to other medical procedures scheduled at the same time (e.g. vitals and lab draws) 

Single ECG, but abnormalities to be confirmed with ECG in triplicate
			Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
		  	HEIGHT AND WEIGHT	Interval: --	Occurrences: --			Nursing Orders
  	ONC NURSING COMMUNICATION 22	Interval: --	Occurrences: --	Comments:	EORTC QLQ-C30, EQ-5D-5L, PRO-CTCAE, single-item GP5, PRO: CTSQ, EORTC QLQ-BR23
§  Administered before patient receives information on disease status
			Imaging
  	MRI BREAST W WO CONTRAST BILATERAL	Interval: --	Occurrences: --	Comments:	o   bilateral mammogram or breast MRI to be performed yearly from that performed at screening/surgery as per clinical practice and/or as clinically indicated based on findings from physical examination.
o   Breast imaging must be performed on both breasts, unless a mastectomy has been performed
		  	MAMMO DIGITAL DIAGNOSTIC BILATERAL	Interval: --	Occurrences: --	Comments:	o   bilateral mammogram or breast MRI to be performed yearly from that performed at screening/surgery as per clinical practice and/or as clinically indicated based on findings from physical examination.
o   Breast imaging must be performed on both breasts, unless a mastectomy has been performed
			Imaging
  	DXA BONE DENSITY EXTERNAL STUDY	Interval: --	Occurrences: --			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
			Labs
  	LIPID PANEL	Interval: --	Occurrences: --	Comments:	Cholesterol, HDL, LDL, triglycerides after at least 8 hours of fasting
			Labs
☑	FOLLICLE STIMULATING HORMONE	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and men and women receiving an LHRH agonist
		☑	ESTRADIOL LEVEL	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and women receiving an LHRH agonist
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	All women of childbearing potential now done monthly.
			Chemotherapy
  	tamoxifen (NOLVADEX) 20 MG chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	letrozole (FEMARA) 2.5 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	anastrozole (ARIMIDEX) 1 mg chemo tablet	Dose: 1 mg	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	exemestane (AROMASIN) 25 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review
					
Cycle 27	Repeat 1 time	Cycle length: 84 days	Day 1	Perform every 1 day x1		Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
			Nursing Orders
  	ONC NURSING COMMUNICATION 62	Interval: --	Occurrences: --	Comments:	Perform limited, symptom-directed exam at specified timepoints or as clinically indicated. During the visit, sites can conduct a general well-being and symptom-directed questionnaire

And ECOG performance score
			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
			Labs
☑	FOLLICLE STIMULATING HORMONE	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and men and women receiving an LHRH agonist
		☑	ESTRADIOL LEVEL	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and women receiving an LHRH agonist
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	All women of childbearing potential now done monthly.
			Chemotherapy
  	tamoxifen (NOLVADEX) 20 MG chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	letrozole (FEMARA) 2.5 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	anastrozole (ARIMIDEX) 1 mg chemo tablet	Dose: 1 mg	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	exemestane (AROMASIN) 25 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review
					
Cycle 30	Repeat 1 time	Cycle length: 84 days	Day 1	Perform every 1 day x1		Nursing Orders
  	ONC NURSING COMMUNICATION 22	Interval: --	Occurrences: --	Comments:	EORTC QLQ-C30, EQ-5D-5L, PRO-CTCAE, single-item GP5, PRO CTSQ

§  Administered before patient receives information on disease status
			Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
			Nursing Orders
  	ONC NURSING COMMUNICATION 62	Interval: --	Occurrences: --	Comments:	Perform limited, symptom-directed exam at specified timepoints or as clinically indicated. During the visit, sites can conduct a general well-being and symptom-directed questionnaire

And ECOG performance score
			Cardiology
  	ECG 12-LEAD	Interval: --	Occurrences: --	Comments:	Performed prior to other medical procedures scheduled at the same time (e.g. vitals and lab draws) 

Single ECG, but abnormalities to be confirmed with ECG in triplicate
			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
			Labs
☑	FOLLICLE STIMULATING HORMONE	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and men and women receiving an LHRH agonist
		☑	ESTRADIOL LEVEL	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and women receiving an LHRH agonist
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	All women of childbearing potential now done monthly.
			Chemotherapy
  	tamoxifen (NOLVADEX) 20 MG chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	letrozole (FEMARA) 2.5 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	anastrozole (ARIMIDEX) 1 mg chemo tablet	Dose: 1 mg	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	exemestane (AROMASIN) 25 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review
					
Cycle 33	Repeat 1 time	Cycle length: 84 days	Day 1	Perform every 1 day x1		Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
			Nursing Orders
  	ONC NURSING COMMUNICATION 62	Interval: --	Occurrences: --	Comments:	Perform limited, symptom-directed exam at specified timepoints or as clinically indicated. During the visit, sites can conduct a general well-being and symptom-directed questionnaire

And ECOG performance score
			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
			Labs
☑	FOLLICLE STIMULATING HORMONE	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and men and women receiving an LHRH agonist
		☑	ESTRADIOL LEVEL	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and women receiving an LHRH agonist
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	All women of childbearing potential now done monthly.
			Chemotherapy
  	tamoxifen (NOLVADEX) 20 MG chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	letrozole (FEMARA) 2.5 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	anastrozole (ARIMIDEX) 1 mg chemo tablet	Dose: 1 mg	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	exemestane (AROMASIN) 25 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review
					
Cycle 36	Repeat 1 time	Cycle length: 84 days	Day 1	Perform every 1 day x1		Nursing Orders
  	ONC NURSING COMMUNICATION 22	Interval: --	Occurrences: --	Comments:	EORTC QLQ-C30, EQ-5D-5L, PRO-CTCAE, single-item GP5, PRO: CTSQ, EORTC QLQ-BR23
§  Administered before patient receives information on disease status
			Cardiology
  	ECG 12-LEAD	Interval: --	Occurrences: --	Comments:	Performed prior to other medical procedures scheduled at the same time (e.g. vitals and lab draws) 

Single ECG, but abnormalities to be confirmed with ECG in triplicate
			Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
		  	HEIGHT AND WEIGHT	Interval: --	Occurrences: --			Nursing Orders
  	ONC NURSING COMMUNICATION 22	Interval: --	Occurrences: --	Comments:	EORTC QLQ-C30, EQ-5D-5L, PRO-CTCAE, single-item GP5, PRO: CTSQ, EORTC QLQ-BR23
§  Administered before patient receives information on disease status
			Imaging
  	MRI BREAST W WO CONTRAST BILATERAL	Interval: --	Occurrences: --	Comments:	o   bilateral mammogram or breast MRI to be performed yearly from that performed at screening/surgery as per clinical practice and/or as clinically indicated based on findings from physical examination.
o   Breast imaging must be performed on both breasts, unless a mastectomy has been performed
		  	MAMMO DIGITAL DIAGNOSTIC BILATERAL	Interval: --	Occurrences: --	Comments:	o   bilateral mammogram or breast MRI to be performed yearly from that performed at screening/surgery as per clinical practice and/or as clinically indicated based on findings from physical examination.
o   Breast imaging must be performed on both breasts, unless a mastectomy has been performed
			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
			Labs
  	LIPID PANEL	Interval: --	Occurrences: --	Comments:	Cholesterol, HDL, LDL, triglycerides after at least 8 hours of fasting
			Labs
☑	FOLLICLE STIMULATING HORMONE	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and men and women receiving an LHRH agonist
		☑	ESTRADIOL LEVEL	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and women receiving an LHRH agonist
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	All women of childbearing potential now done monthly.
			Chemotherapy
  	tamoxifen (NOLVADEX) 20 MG chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	letrozole (FEMARA) 2.5 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	anastrozole (ARIMIDEX) 1 mg chemo tablet	Dose: 1 mg	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	exemestane (AROMASIN) 25 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review
					
Cycle 39	Repeat 1 time	Cycle length: 84 days	Day 1	Perform every 1 day x1		Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
			Nursing Orders
  	ONC NURSING COMMUNICATION 62	Interval: --	Occurrences: --	Comments:	Perform limited, symptom-directed exam at specified timepoints or as clinically indicated. During the visit, sites can conduct a general well-being and symptom-directed questionnaire

And ECOG performance score
			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
			Labs
☑	FOLLICLE STIMULATING HORMONE	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and men and women receiving an LHRH agonist
		☑	ESTRADIOL LEVEL	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and women receiving an LHRH agonist
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	All women of childbearing potential now done monthly.
			Chemotherapy
  	tamoxifen (NOLVADEX) 20 MG chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	letrozole (FEMARA) 2.5 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	anastrozole (ARIMIDEX) 1 mg chemo tablet	Dose: 1 mg	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	exemestane (AROMASIN) 25 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review
					
Cycle 42	Repeat 1 time	Cycle length: 84 days	Day 1	Perform every 1 day x1		Nursing Orders
  	ONC NURSING COMMUNICATION 22	Interval: --	Occurrences: --	Comments:	EORTC QLQ-C30, EQ-5D-5L, PRO-CTCAE, single-item GP5, PRO CTSQ

§  Administered before patient receives information on disease status
			Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
			Nursing Orders
  	ONC NURSING COMMUNICATION 62	Interval: --	Occurrences: --	Comments:	Perform limited, symptom-directed exam at specified timepoints or as clinically indicated. During the visit, sites can conduct a general well-being and symptom-directed questionnaire

And ECOG performance score
			Cardiology
  	ECG 12-LEAD	Interval: --	Occurrences: --	Comments:	Performed prior to other medical procedures scheduled at the same time (e.g. vitals and lab draws) 

Single ECG, but abnormalities to be confirmed with ECG in triplicate
			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
			Labs
☑	FOLLICLE STIMULATING HORMONE	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and men and women receiving an LHRH agonist
		☑	ESTRADIOL LEVEL	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and women receiving an LHRH agonist
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	All women of childbearing potential now done monthly.
			Chemotherapy
  	tamoxifen (NOLVADEX) 20 MG chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	letrozole (FEMARA) 2.5 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	anastrozole (ARIMIDEX) 1 mg chemo tablet	Dose: 1 mg	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	exemestane (AROMASIN) 25 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review
					
Cycle 45	Repeat 1 time	Cycle length: 84 days	Day 1	Perform every 1 day x1		Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
			Nursing Orders
  	ONC NURSING COMMUNICATION 62	Interval: --	Occurrences: --	Comments:	Perform limited, symptom-directed exam at specified timepoints or as clinically indicated. During the visit, sites can conduct a general well-being and symptom-directed questionnaire

And ECOG performance score
			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
			Labs
☑	FOLLICLE STIMULATING HORMONE	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and men and women receiving an LHRH agonist
		☑	ESTRADIOL LEVEL	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and women receiving an LHRH agonist
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	All women of childbearing potential now done monthly.
			Chemotherapy
  	tamoxifen (NOLVADEX) 20 MG chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	letrozole (FEMARA) 2.5 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	anastrozole (ARIMIDEX) 1 mg chemo tablet	Dose: 1 mg	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	exemestane (AROMASIN) 25 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review
					
Cycle 48	Repeat 1 time	Cycle length: 84 days	Day 1	Perform every 1 day x1		Nursing Orders
  	ONC NURSING COMMUNICATION 22	Interval: --	Occurrences: --	Comments:	EORTC QLQ-C30, EQ-5D-5L, PRO-CTCAE, single-item GP5, PRO: CTSQ, EORTC QLQ-BR23
§  Administered before patient receives information on disease status
			Cardiology
  	ECG 12-LEAD	Interval: --	Occurrences: --	Comments:	Performed prior to other medical procedures scheduled at the same time (e.g. vitals and lab draws) 

Single ECG, but abnormalities to be confirmed with ECG in triplicate
			Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
		  	HEIGHT AND WEIGHT	Interval: --	Occurrences: --			Nursing Orders
  	ONC NURSING COMMUNICATION 22	Interval: --	Occurrences: --	Comments:	EORTC QLQ-C30, EQ-5D-5L, PRO-CTCAE, single-item GP5, PRO: CTSQ, EORTC QLQ-BR23
§  Administered before patient receives information on disease status
			Imaging
  	MRI BREAST W WO CONTRAST BILATERAL	Interval: --	Occurrences: --	Comments:	o   bilateral mammogram or breast MRI to be performed yearly from that performed at screening/surgery as per clinical practice and/or as clinically indicated based on findings from physical examination.
o   Breast imaging must be performed on both breasts, unless a mastectomy has been performed
		  	MAMMO DIGITAL DIAGNOSTIC BILATERAL	Interval: --	Occurrences: --	Comments:	o   bilateral mammogram or breast MRI to be performed yearly from that performed at screening/surgery as per clinical practice and/or as clinically indicated based on findings from physical examination.
o   Breast imaging must be performed on both breasts, unless a mastectomy has been performed
			Imaging
  	DXA BONE DENSITY EXTERNAL STUDY	Interval: --	Occurrences: --			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
			Labs
  	LIPID PANEL	Interval: --	Occurrences: --	Comments:	Cholesterol, HDL, LDL, triglycerides after at least 8 hours of fasting
			Labs
☑	FOLLICLE STIMULATING HORMONE	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and men and women receiving an LHRH agonist
		☑	ESTRADIOL LEVEL	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and women receiving an LHRH agonist
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	All women of childbearing potential now done monthly.
			Chemotherapy
  	tamoxifen (NOLVADEX) 20 MG chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	letrozole (FEMARA) 2.5 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	anastrozole (ARIMIDEX) 1 mg chemo tablet	Dose: 1 mg	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	exemestane (AROMASIN) 25 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review
					
Cycle 51	Repeat 1 time	Cycle length: 84 days	Day 1	Perform every 1 day x1		Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
			Nursing Orders
  	ONC NURSING COMMUNICATION 62	Interval: --	Occurrences: --	Comments:	Perform limited, symptom-directed exam at specified timepoints or as clinically indicated. During the visit, sites can conduct a general well-being and symptom-directed questionnaire

And ECOG performance score
			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
			Labs
☑	FOLLICLE STIMULATING HORMONE	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and men and women receiving an LHRH agonist
		☑	ESTRADIOL LEVEL	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and women receiving an LHRH agonist
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	All women of childbearing potential now done monthly.
			Chemotherapy
  	tamoxifen (NOLVADEX) 20 MG chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	letrozole (FEMARA) 2.5 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	anastrozole (ARIMIDEX) 1 mg chemo tablet	Dose: 1 mg	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	exemestane (AROMASIN) 25 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review
					
Cycle 54	Repeat 1 time	Cycle length: 84 days	Day 1	Perform every 1 day x1		Nursing Orders
  	ONC NURSING COMMUNICATION 22	Interval: --	Occurrences: --	Comments:	EORTC QLQ-C30, EQ-5D-5L, PRO-CTCAE, single-item GP5, PRO CTSQ

§  Administered before patient receives information on disease status
			Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
			Nursing Orders
  	ONC NURSING COMMUNICATION 62	Interval: --	Occurrences: --	Comments:	Perform limited, symptom-directed exam at specified timepoints or as clinically indicated. During the visit, sites can conduct a general well-being and symptom-directed questionnaire

And ECOG performance score
			Cardiology
  	ECG 12-LEAD	Interval: --	Occurrences: --	Comments:	Performed prior to other medical procedures scheduled at the same time (e.g. vitals and lab draws) 

Single ECG, but abnormalities to be confirmed with ECG in triplicate
			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
			Labs
☑	FOLLICLE STIMULATING HORMONE	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and men and women receiving an LHRH agonist
		☑	ESTRADIOL LEVEL	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and women receiving an LHRH agonist
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	All women of childbearing potential now done monthly.
			Chemotherapy
  	tamoxifen (NOLVADEX) 20 MG chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	letrozole (FEMARA) 2.5 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	anastrozole (ARIMIDEX) 1 mg chemo tablet	Dose: 1 mg	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	exemestane (AROMASIN) 25 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review
					
Cycle 57	Repeat 1 time	Cycle length: 84 days	Day 1	Perform every 1 day x1		Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
			Nursing Orders
  	ONC NURSING COMMUNICATION 62	Interval: --	Occurrences: --	Comments:	Perform limited, symptom-directed exam at specified timepoints or as clinically indicated. During the visit, sites can conduct a general well-being and symptom-directed questionnaire

And ECOG performance score
			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
			Labs
☑	FOLLICLE STIMULATING HORMONE	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and men and women receiving an LHRH agonist
		☑	ESTRADIOL LEVEL	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and women receiving an LHRH agonist
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	All women of childbearing potential now done monthly.
			Chemotherapy
  	tamoxifen (NOLVADEX) 20 MG chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	letrozole (FEMARA) 2.5 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	anastrozole (ARIMIDEX) 1 mg chemo tablet	Dose: 1 mg	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	exemestane (AROMASIN) 25 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review
					
Cycle 60	Repeat 1 time	Cycle length: 84 days	Day 1	Perform every 1 day x1		Nursing Orders
  	ONC NURSING COMMUNICATION 22	Interval: --	Occurrences: --	Comments:	EORTC QLQ-C30, EQ-5D-5L, PRO-CTCAE, single-item GP5, PRO: CTSQ, EORTC QLQ-BR23
§  Administered before patient receives information on disease status
			Cardiology
  	ECG 12-LEAD	Interval: --	Occurrences: --	Comments:	Performed prior to other medical procedures scheduled at the same time (e.g. vitals and lab draws) 

Single ECG, but abnormalities to be confirmed with ECG in triplicate
			Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
		  	HEIGHT AND WEIGHT	Interval: --	Occurrences: --			Nursing Orders
  	ONC NURSING COMMUNICATION 22	Interval: --	Occurrences: --	Comments:	EORTC QLQ-C30, EQ-5D-5L, PRO-CTCAE, single-item GP5, PRO: CTSQ, EORTC QLQ-BR23
§  Administered before patient receives information on disease status
			Imaging
  	MRI BREAST W WO CONTRAST BILATERAL	Interval: --	Occurrences: --	Comments:	o   bilateral mammogram or breast MRI to be performed yearly from that performed at screening/surgery as per clinical practice and/or as clinically indicated based on findings from physical examination.
o   Breast imaging must be performed on both breasts, unless a mastectomy has been performed
		  	MAMMO DIGITAL DIAGNOSTIC BILATERAL	Interval: --	Occurrences: --	Comments:	o   bilateral mammogram or breast MRI to be performed yearly from that performed at screening/surgery as per clinical practice and/or as clinically indicated based on findings from physical examination.
o   Breast imaging must be performed on both breasts, unless a mastectomy has been performed
			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
			Labs
  	LIPID PANEL	Interval: --	Occurrences: --	Comments:	Cholesterol, HDL, LDL, triglycerides after at least 8 hours of fasting
			Labs
☑	FOLLICLE STIMULATING HORMONE	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and men and women receiving an LHRH agonist
		☑	ESTRADIOL LEVEL	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and women receiving an LHRH agonist
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	All women of childbearing potential now done monthly.
			Chemotherapy
  	tamoxifen (NOLVADEX) 20 MG chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	letrozole (FEMARA) 2.5 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	anastrozole (ARIMIDEX) 1 mg chemo tablet	Dose: 1 mg	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	exemestane (AROMASIN) 25 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review
					
End of Treatment	Repeat 1 time	Cycle length: 1 day	Day 1	Perform every 1 day x1		Nursing Orders
  	ONC NURSING COMMUNICATION 22	Interval: --	Occurrences: --	Comments:	EORTC QLQ-C30, EQ-5D-5L, PRO-CTCAE, single-item GP5, PRO: CTSQ, EORTC QLQ-BR23
§  Administered before patient receives information on disease status
			Cardiology
  	ECG 12-LEAD	Interval: --	Occurrences: --	Comments:	Performed prior to other medical procedures scheduled at the same time (e.g. vitals and lab draws) 

Single ECG, but abnormalities to be confirmed with ECG in triplicate
			Nursing Orders
  	RESEARCH - VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	while seated
		  	HEIGHT AND WEIGHT	Interval: --	Occurrences: --			Imaging
  	DXA BONE DENSITY EXTERNAL STUDY	Interval: --	Occurrences: --			Nursing Orders
  	ONC NURSING COMMUNICATION 2	Interval: --	Occurrences: --	Comments:	Clinical examination of breast/chest wall and axilla
			Labs
☑	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		☑	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --			Labs
☑	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --	Comments:	WBC count, RBC count, hemoglobin, hematocrit, platelet count, and differential count (neutrophils, eosinophils, basophils, monocytes, lymphocytes, and other cells)
		☑	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --	Comments:	§  sodium, potassium, chloride, glucose, BUN or urea, creatinine, total protein, albumin, calcium, total bilirubin (if total bilirubin is 2x ULN, also record direct bilirubin), ALP, ALT, AST
			Labs
  	LIPID PANEL	Interval: --	Occurrences: --	Comments:	Cholesterol, HDL, LDL, triglycerides after at least 8 hours of fasting
			Labs
☑	FOLLICLE STIMULATING HORMONE	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and men and women receiving an LHRH agonist
		☑	ESTRADIOL LEVEL	Interval: --	Occurrences: --	Comments:	Applicable for pre-and perimenopausal women, women < 60 years old, and women receiving an LHRH agonist
			Labs
  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	All women of childbearing potential now done monthly.
			Chemotherapy
  	tamoxifen (NOLVADEX) 20 MG chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	letrozole (FEMARA) 2.5 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	anastrozole (ARIMIDEX) 1 mg chemo tablet	Dose: 1 mg	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.		  	exemestane (AROMASIN) 25 mg chemo tablet	Dose: --	Route: oral	daily	Dispense: --	Refills: --				Comments:	Dose reductions not permitted.			Nursing Orders
  	ONC NURSING COMMUNICATION	Interval: --	Occurrences: --	Comments:	The order may include, but aren't limited to leuprolide acetate, goserelin acetate, or triptorelin pamoate.
			Nursing Orders
  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	LHRH administration if applicable
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Concomitant medication review
		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	Adverse Event Review